Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05),...

FDA Recall #D-0101-2018 — Class II — November 20, 2017

Recall #D-0101-2018 Date: November 20, 2017 Classification: Class II Status: Terminated

Product Description

Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534

Reason for Recall

Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets

Recalling Firm

Zydus Pharmaceuticals USA Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

19812 bottles

Distribution

Nationwide

Code Information

a) Z701308, b) Z701309, c) Z701310 exp April 2019

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated